Pharmaceutical Sterility Testing Market Report 2023 | R&D Consistency Drives Sector Growth

Posted by Ganesh Shinde on June 12th, 2023

The Pharmaceutical Sterility Testing Market Size is predicted to be worth US$ 1,250.7 Million in 2023 and rise to US$ 3,815.6 Million by 2033 with a CAGR of 11.8%. The global industry was expanding at a CAGR of 9.8% from 2018 to 2022.

The demand for effective medications is predicted to rise as the prevalence of chronic diseases rises. This drives the requirement for sterility testing of products before their release onto the market and supports global market expansion.

To reduce the possibility of product contamination, Pharmaceutical Sterility Testing is done at every stage of the production of pharmaceutical and biological goods. The frequency of sterility testing in industries is rising, along with the demand for pharmaceutical and medical products for various health issues.

Potential Market Opportunity:

An increase in research and development expenditures in the biopharmaceutical industry contributed to the market's expansion. For instance, in December 2021, the pharmaceutical industry's annual research and development spending was 7.3 times higher than that of the aerospace and defense industries. Moreover, it was 6.5 times higher than that of the chemicals industry and 1.5 times higher than that of the software industry.

Major Players:

• Merck KGaA
• bioMerieux SA
• Thermo Fisher Scientific Inc.
• Charles River Laboratories International Inc.
• Others

Read More@ https://www.futuremarketinsights.com/reports/pharmaceutical-sterility-testing-market

Key Segments:

By Product:

• Kits and Reagents
• Instruments

By Application:

• Sterile Drugs
• Biologics and Therapeutics
• Medical Devices

By Test Type:

• Sterility Testing

• • Membrane Filtration
  • Direct Inoculation
• Bacterial Endotoxin Testing
• Rapid Micro Test
• Container Closure Integrity Testing
• Electrical Resistance
• Bioburden Testing
• ATP Bioluminescence
• Fluorescent Labeling
• Others

By Services:

• In-House
• Outsourced

By End Use:

• Compounding Pharmacies
• Medical Devices Companies
• Pharmaceutical Companies